Singaporean Biotech To Go Public Via $1.5B SPAC Merger
By Jade Martinez-Pogue · October 2, 2025, 4:14 PM EDT
Singapore-based biotechnology company Nanyang Biologics Pte. Ltd. on Thursday announced plans to go public in the U.S. by merging with special purpose acquisition company RF Acquisition Corp. II in a deal...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login